Genexine Inc. is > 10% Shareholder of Rezolute, Inc.. Currently has a direct ownership of 91.3 Million shares of RZLT, which is worth approximately $402 Million. The most recent transaction as insider was on Jul 23, 2019, when has been sold 34,482,758 shares (Common Stock) at a price of $0.29 per share, resulting in proceeds of $10,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 91.3M
0% 3M change
0% 12M change
Total Value Held $402 Million

Genexine Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 23 2019
BUY
Open market or private purchase
$10,000,000 $0.29 p/Share
34,482,758 Added 27.41%
91,300,933 Common Stock
Apr 26 2019
BUY
Conversion of derivative security
-
56,818,175 Added 50.0%
56,818,175 Common Stock
GI

Genexine Inc.

> 10% Shareholder
Seongnam Si, Gyeonggi Do, M5

Track Institutional and Insider Activities on RZLT

Follow Rezolute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RZLT shares.

Notify only if

Insider Trading

Get notified when an Rezolute, Inc. insider buys or sells RZLT shares.

Notify only if

News

Receive news related to Rezolute, Inc.

Track Activities on RZLT